Prelude Therapeutics PRLD
NASDAQ PRLD
$3.90 -0.06 (-1.39%)
As of: Sep 30, 2026 · 3:59 PM EDT

Prelude Therapeutics (PRLD) Other Non-Current Liabilities (2019 - 2026)

Updated

Prelude Therapeutics' Other Non-Current Liabilities came in at $2.72 million for Q2 2026, down 8.4% from $2.97 million a year earlier and down 2.2% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

At the end of FY2025, Prelude Therapeutics' Other Non-Current Liabilities was $2.84 million, down 8.1% from FY2024.

  • Other Non-Current Liabilities has declined in each of the last three years, though with a five-year compound annual growth rate of 145.3% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Liabilities was $3.09 million in FY2024 (-7.5%), $3.34 million in FY2023 (-0.7%) and $3.36 million in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Other Non-Current Liabilities since Q2 2022.
  • Year-over-year, Other Non-Current Liabilities has declined for 11 consecutive quarters, with an average decline of 7.7% over the last eight quarters.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2023 (growth of 40.0%), and the weakest in Q2 2026 (a decline of 8.4%).
  • Business Quant data shows PRLD's Other Non-Current Liabilities at $2.78 million (Q1 2026), $2.84 million (Q4 2025) and $2.9 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Prelude Therapeutics 316.02 Mn -281.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.72 Mn
Mar 31, 2026 2.78 Mn
Dec 31, 2025 2.84 Mn
Sep 30, 2025 2.90 Mn
Jun 30, 2025 2.97 Mn
Mar 31, 2025 3.03 Mn
Dec 31, 2024 3.09 Mn
Sep 30, 2024 3.15 Mn
Jun 30, 2024 3.22 Mn
Mar 31, 2024 3.28 Mn
Dec 31, 2023 3.34 Mn
Sep 30, 2023 3.36 Mn
Jun 30, 2023 3.36 Mn
Mar 31, 2023 3.36 Mn
Dec 31, 2022 3.36 Mn
Sep 30, 2022 3.36 Mn
Jun 30, 2022 2.40 Mn
Mar 31, 2022 2.40 Mn
Dec 31, 2020 32,000.00
Sep 30, 2020 15,000.00
API Access

Prelude Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PRLD&period=max&api_key=YOUR_API_KEY